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1. Calculate the score as recommended
Patient-reported outcome measures (PROMs) are becoming 
more common in orthopedic studies. PROMs are question-
naires from which 1 or several scores can be calculated. It is 
important to calculate the score(s) according to the instruc-
tions by the developers, so as not to threaten the validity of 
the measure.
For the Knee injury and Osteoarthritis Outcome Score 
(KOOS) the 5 subscale scores for Pain, Other Symptoms, 
Activities of Daily Living (ADL), Sport and Recreation func-
tion (Sport/Rec), and knee-related Quality of Life (QOL) 
should be calculated and reported separately on a 0–100, worst 
to best, scale (Roos 2012). Although calculating a total KOOS 
score is not recommended (Roos 2012) a total KOOS score has 
been reported in many orthopedic papers. The KOOS subscales 
hold from 4 to 17 items each and summing all items across the 
subscales will give very different weights to the fi ve subscales. 
As an example, 40% of the contribution to a total score would 
originate from items related to diffi culty with activities of daily 
living. Reporting a total score threatens the validity of the 
KOOS for many patient groups, including younger individuals 
with knee injury where function during sport and recreation 
and knee-related quality of life are subscales of greater rele-
vance, and older subjects with knee osteoarthritis where pain 
is a subscale of equal or greater relevance compared with diffi -
culty with function during daily activities (Collins et al. 2016).
2. Report confi dence intervals instead of p-values
The recommended way to report PROM scores in clinical 
trials is to give the mean change score with its 95% confi dence 
interval (95% CI), outlining the uncertainty of the estimated 
mean change score. Measures of uncertainty (and effect sizes) 
are instrumental in understanding the results and in clinical 
decision-making. The use of p-values is discouraged by many 
journals, including Acta Orthopedica (Ranstam 2005, 2012). 
Reasons for this include p-values being blamed for “distorting 
readers’ perception of observed results,” p-values not provid-
ing a direct estimate of how likely a result is to be true or not 
true, the p-value not being a measure of effect size, and “read-
ers mistaking statistical signifi cance for clinical signifi cance” 
(Bhandari et al. 2005).
3. Clinical interpretation and the appealing but devi-
ous concept Minimal Important Change (MIC)
A statistically signifi cant difference in PROM score is not 
necessarily equivalent to a clinically relevant fi nding. To help 
establish clinical relevance, the concept “minimal important 
change” (MIC) has been introduced. The MIC value is used 
to determine whether the mean change found within a group 
over time is considered clinically relevant. Commonly it is 
also applied in randomized controlled trials (RCTs) to evalu-
ate whether the mean difference in longitudinal change found 
between 2 groups is clinically relevant.
Interpretation of clinical relevance, and the MIC concept as 
such, may not be as straightforward and simple as we would 
wish for. In fact, studies in orthopedics, and across medi-
cal disciplines, have found that the MIC value for a specifi c 
PROM varies with defi nition and calculation method used 
(at least 14 defi nitions have been put forward since 1987), 
wording of the anchor question, and the response options 
used when determining the MIC with anchor-based methods 
(examples include if we are asking for “change” or “impor-
tant change” and what cut-off is chosen, for example “a little 
better,” “somewhat better,” or “better”), patient characteristics, 
type of intervention undergone (if any), and time to follow-up. 
In summary, it is increasingly being recognized that there is 
no such thing as a single MIC value that is applicable for a 
PROM across contexts (King 2011).
AnnRoos D.indd   1 1/3/2018   11:26:35 AM
2 Acta Orthopaedica 2018; 89 (1): 1–2
For the purpose of this Annotation let us say a MIC value 
of 12 has been suggested for the KOOS subscale Sport/Rec 
in young adults following reconstruction of the anterior cru-
ciate ligament of the knee (ACLR). The recommended way 
to apply this MIC is to calculate and report the proportion of 
individuals with a score improvement of at least 12 following 
ACLR. Individuals with a score improvement of at least 12 
are categorized as “responders.” In a comparative trial, the 
proportion of responders in the 2 treatment groups should be 
reported. If a responder analysis was the pre-specifi ed anal-
ysis method for the trial, the proportions of responders are 
compared statistically. A more important aspect to consider, 
however, is whether the difference in proportions of respond-
ers in the 2 groups indicates a change in clinical care. For 
example, will a difference in responders of 10% prompt cli-
nicians to prefer and recommend the new treatment instead 
of the old or is the extra 10% of responders considered to 
be a marginal improvement not suffi cient to warrant a new 
treatment being introduced? And what if the difference in 
proportions of responders were 20% or 30%: would any of 
those differences in success rates make patients, clinicians, 
and health care administrators prefer the new treatment? This 
is a discussion authors need to have prior to starting a study 
comparing 2 treatments.
Despite some authors questioning the MIC concept as such, 
there is agreement that clinical interpretation of study results is 
of utmost importance. An alternative approach is to perform a 
responder analysis and report 20% and 50% improvements in 
the PROM score as moderate and large response rates, respec-
tively (Felson et al. 1993, Escobar et al. 2012). This approach 
may also be applied in the increasing number of RCTs in 
orthopedics comparing interventions of different risk and cost 
profi les. In these studies it is not granted that similar improve-
ments are required in the two groups to defi ne a successful 
outcome. In patients with knee problems, it may be that clini-
cians and administrators would consider a 20% improvement 
in PROM score satisfactory following a low-risk and cheap 
intervention such as exercise therapy while a 50% improve-
ment would be required for a satisfactory result following sur-
gery because of its greater invasiveness, risk, and higher cost. 
On the other hand, it may be that patients perceive exercise 
as time-consuming, boring, and uncomfortable, while surgery, 
hospital stay, and rehabilitation is more tolerable since it is 
often believed to be necessary to improve the condition. To 
facilitate interpretation of the results, authors (and patients) 
would have to decide a priori what level of improvement con-
stitutes a success for the treatments compared and what differ-
ence in success rates between the respective treatments would 
indicate a change in clinical recommendation.
Commonly, including by me, the MIC has been used to 
evaluate whether between-group differences are clinically rel-
evant. It is, however, no longer obvious to me and others (Katz 
et al. 2015) that a MIC value, always calculated from longi-
tudinal within-group data, can be applied between groups and 
used for calculation of the sample size needed to determine 
a between-group difference in mean PROM score. Applying 
responder analysis to KOOS data in orthopedic studies seems 
to solve this dilemma.
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